[1]
Ananda M. Chakrabarty 2016. COMMENTARY: BRCA1/2 Mutations, Vulnerability to Breast/Ovarian Cancer, and Current and Future Treatment Modalities. Journal of Cancer Research Updates. 5, 2 (Mar. 2016),  45–46. DOI:https://doi.org/10.6000/1929-2279.2016.05.02.1.